Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples.
Human enteric viruses can be present in untreated and inadequately treated drinking water. Molecular methods, such as the reverse transcriptase PCR (RT-PCR), can detect viral genomes in a few hours, but they cannot distinguish between infectious and noninfectious viruses. Since only infectious viruses are a public health concern, methods that not only are rapid but also provide information on the infectivity of viruses are of interest. The intercalating dye propidium monoazide (PMA) has been used for distinguishing between viable and nonviable bacteria with DNA genomes, but it has not been used to distinguish between infectious and noninfectious enteric viruses with RNA genomes. In this study, PMA in conjunction with RT-PCR (PMA-RT-PCR) was used to determine the infectivity of enteric RNA viruses in water. Coxsackievirus, poliovirus, echovirus, and Norwalk virus were rendered noninfectious or inactivated by treatment with heat (72 degrees C, 37 degrees C, and 19 degrees C) or hypochlorite. Infectious or native and noninfectious or inactivated viruses were treated with PMA. This was followed by RNA extraction and RT-PCR or quantitative RT-PCR (qRT-PCR) analysis. The PMA-RT-PCR results indicated that PMA treatment did not interfere with detection of infectious or native viruses but prevented detection of noninfectious or inactivated viruses that were rendered noninfectious or inactivated by treatment at 72 degrees C and 37 degrees C and by hypochlorite treatment. However, PMA-RT-PCR was unable to prevent detection of enteroviruses that were rendered noninfectious by treatment at 19 degrees C. After PMA treatment poliovirus that was rendered noninfectious by treatment at 37 degrees C was undetectable by qRT-PCR, but PMA treatment did not affect detection of Norwalk virus. PMA-RT-PCR was also shown to be effective for detecting infectious poliovirus in the presence of noninfectious virus and in an environmental matrix. We concluded that PMA can be used to differentiate between potentially infectious and noninfectious viruses under the conditions defined above.
Parshionikar
Sandhya
S
Technical Support Center, U.S. Environmental Protection Agency, Mailstop 140, 26 W. Martin Luther King Dr., Cincinnati, OH 45268, USA. parshionikar.sandhya@epa.gov
Laseke
Ian
I
Fout
G Shay
GS
D001386:Azides / Q000494:pharmacology*; D029822:Enterovirus B, Human / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D006358:Hot Temperature; D006801:Humans; D006997:Hypochlorous Acid / Q000494:pharmacology; D009663:Norwalk virus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D017955:Poliovirus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D011419:Propidium / Q000031:analogs & derivatives* / Q000494:pharmacology; D012328:RNA Viruses / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity*; D012367:RNA, Viral / Q000032:analysis / Q000302:isolation & purification; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D045483:Rivers / Q000821:virology*
D001386:Azides; D012367:RNA, Viral; C533957:propidium monoazide; D011419:Propidium; D006997:Hypochlorous Acid
Semin Pediatr Infect Dis. 2002 Jan;13(1):40-7
12118843
Appl Environ Microbiol. 2007 Dec;73(24):8028-31
17933922
J Appl Microbiol. 2004;97(5):1105-12
15479428
J Virol. 1994 Jun;68(6):3965-70
7514682
J Microbiol Methods. 2007 Dec;71(3):336-9
17936386
FEMS Microbiol Lett. 2009 Feb;291(2):137-42
19054073
Appl Environ Microbiol. 1986 Apr;51(4):790-812
3010860
J Food Prot. 2006 Nov;69(11):2761-5
17133824
J Infect Dis. 1986 Nov;154(5):871-80
3021869
Appl Environ Microbiol. 1978 Sep;36(3):480-6
215087
J Infect Dis. 2003 Jan 15;187(2):303-6
12552455
RNA Biol. 2006 Apr;3(2):60-8
17114941
J Infect Dis. 1999 Dec;180(6):1771-6
10558930
Appl Environ Microbiol. 2003 Jul;69(7):3965-9
12839768
Environ Health Perspect. 2007 Jun;115(6):856-64
17589591
J Microbiol Methods. 2006 Nov;67(2):310-20
16753236
Rev Clin Esp. 2006 Oct;206(9):435-7
17094221
J Microbiol Methods. 2007 Aug;70(2):252-60
17544161
Appl Environ Microbiol. 1991 Nov;57(11):3243-7
1723585
J Microbiol Methods. 2008 Feb;72(2):180-4
18160156
J Virol Methods. 2010 Mar;164(1-2):51-4
19941905
Appl Environ Microbiol. 2003 Sep;69(9):5263-8
12957912
Appl Environ Microbiol. 2008 Jan;74(2):477-84
18065626
Clin Infect Dis. 2007 Feb 15;44(4):506-12
17243052
J Clin Microbiol. 1998 Dec;36(12):3590-4
9817878
Cent Eur J Public Health. 2006 Jun;14(2):67-73
16830607
Appl Environ Microbiol. 2003 Dec;69(12):7377-84
14660388
Appl Environ Microbiol. 1996 Apr;62(4):1424-7
8919804
J Virol Methods. 2004 Jun 1;118(1):49-59
15158068
J Med Virol. 2008 Aug;80(8):1468-76
18551613
Appl Environ Microbiol. 2000 Jun;66(6):2520-5
10831432
Emerg Infect Dis. 2007 Mar;13(3):396-403
17552092
Methods Mol Biol. 2004;268:69-78
15156019
Appl Environ Microbiol. 2003 Jan;69(1):350-7
12514015
Biomed Environ Sci. 2008 Oct;21(5):425-31
19133617
Appl Environ Microbiol. 2008 Apr;74(8):2537-9
18296534
Appl Environ Microbiol. 2008 Jan;74(2):543-6
18024676
Virology. 1989 Feb;168(2):201-9
2536978
Can J Microbiol. 2004 Apr;50(4):269-78
15213751
Appl Environ Microbiol. 2009 Jan;75(2):297-307
19011062
J Mol Biol. 1965 Aug;13(1):269-82
5859041
J Virol Methods. 2004 Oct;121(1):39-48
15350731
J Virol Methods. 2009 Mar;156(1-2):89-95
19028524
J Virol Methods. 2002 Jul;104(2):217-25
12088831
Appl Environ Microbiol. 2009 Nov;75(21):6856-63
19749067
Appl Environ Microbiol. 2003 Jun;69(6):3158-64
12788711